Literature DB >> 1351231

HIV-1 viraemia and influenza.

D D Ho.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1351231     DOI： 10.1016/0140-6736(92)91321-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  22 in total

Review 1.  Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.

Authors:  Ken M Kunisaki; Edward N Janoff
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

2.  Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways.

Authors:  A Blauvelt; H Asada; M W Saville; V Klaus-Kovtun; D J Altman; R Yarchoan; S I Katz
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Short communication: HIV type 1 accumulates in influenza-specific T cells in subjects receiving seasonal vaccination in the context of effective antiretroviral therapy.

Authors:  R Brad Jones; Colin Kovacs; Tae-Wook Chun; Mario A Ostrowski
Journal:  AIDS Res Hum Retroviruses       Date:  2012-08-14       Impact factor: 2.205

Review 4.  Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection.

Authors:  D Weissman; A S Fauci
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 5.  Effect of treating co-infections on HIV-1 viral load: a systematic review.

Authors:  Kayvon Modjarrad; Sten H Vermund
Journal:  Lancet Infect Dis       Date:  2010-07       Impact factor: 25.071

6.  Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispecies.

Authors:  M A Ostrowski; D C Krakauer; Y Li; S J Justement; G Learn; L A Ehler; S K Stanley; M Nowak; A S Fauci
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  In vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or human immunodeficiency virus-infected individuals.

Authors:  Y Sasaki; A Blanchard; H L Watson; S Garcia; A Dulioust; L Montagnier; M L Gougeon
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

8.  Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire.

Authors:  Joseph P Casazza; Kathryn A Bowman; Selorm Adzaku; Emily C Smith; Mary E Enama; Robert T Bailer; David A Price; Emma Gostick; Ingelise J Gordon; David R Ambrozak; Martha C Nason; Mario Roederer; Charla A Andrews; Frank M Maldarelli; Ann Wiegand; Mary F Kearney; Deborah Persaud; Carrie Ziemniak; Raphael Gottardo; Julie E Ledgerwood; Barney S Graham; Richard A Koup
Journal:  J Infect Dis       Date:  2013-03-12       Impact factor: 5.226

9.  Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus.

Authors:  K D Bell; O Ramilo; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

10.  Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults.

Authors:  Filippo Ansaldi; Laura Valle; Daniela de Florentiis; Valentina Parodi; Giuseppe Murdaca; Bianca Bruzzone; Paolo Durando; Maurizio Setti; Giancarlo Icardi
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.